These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28609670)

  • 1. Differential effects of the 18-kDa translocator protein (TSPO) ligand etifoxine on steroidogenesis in rat brain, plasma and steroidogenic glands: Pharmacodynamic studies.
    Liere P; Pianos A; Oudinet JP; Schumacher M; Akwa Y
    Psychoneuroendocrinology; 2017 Sep; 83():122-134. PubMed ID: 28609670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Anxiolytic Etifoxine Binds to TSPO Ro5-4864 Binding Site with Long Residence Time Showing a High Neurosteroidogenic Activity.
    Costa B; Cavallini C; Da Pozzo E; Taliani S; Da Settimo F; Martini C
    ACS Chem Neurosci; 2017 Jul; 8(7):1448-1454. PubMed ID: 28362078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The anxiolytic etifoxine activates the peripheral benzodiazepine receptor and increases the neurosteroid levels in rat brain.
    Verleye M; Akwa Y; Liere P; Ladurelle N; Pianos A; Eychenne B; Schumacher M; Gillardin JM
    Pharmacol Biochem Behav; 2005 Dec; 82(4):712-20. PubMed ID: 16388839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The non-benzodiazepine anxiolytic drug etifoxine causes a rapid, receptor-independent stimulation of neurosteroid biosynthesis.
    do Rego JL; Vaudry D; Vaudry H
    PLoS One; 2015; 10(3):e0120473. PubMed ID: 25785994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dissociation of endocrine responses to the Trier Social Stress Test in Virtual Reality (VR-TSST) by the benzodiazepine alprazolam and the translocator protein 18 kDa (TSPO) ligand etifoxine.
    Bahr LM; Maurer F; Weigl J; Weber K; Melchner D; Dörfelt A; Wechsler TF; Bauer O; Reinders J; Milenkovic VM; Wetzel CH; Wetter TC; Rupprecht R; Mühlberger A; Nothdurfter C
    Psychoneuroendocrinology; 2021 Feb; 124():105100. PubMed ID: 33338971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of Traumatic Brain Damage by Tspo Ligand Etifoxine.
    Shehadeh M; Palzur E; Apel L; Soustiel JF
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31146356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex-dependent changes in neuroactive steroid concentrations in the rat brain following acute swim stress.
    Sze Y; Gill AC; Brunton PJ
    J Neuroendocrinol; 2018 Nov; 30(11):e12644. PubMed ID: 30194779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal changes in the expression of the translocator protein TSPO and the steroidogenic enzyme 5α-reductase in the dorsal spinal cord of animals with neuropathic pain: Effects of progesterone administration.
    Coronel MF; Sánchez Granel ML; Raggio MC; Adler NS; De Nicola AF; Labombarda F; González SL
    Neurosci Lett; 2016 Jun; 624():23-8. PubMed ID: 27150077
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroprotective effects of a ligand of translocator protein-18 kDa (Ro5-4864) in experimental diabetic neuropathy.
    Giatti S; Pesaresi M; Cavaletti G; Bianchi R; Carozzi V; Lombardi R; Maschi O; Lauria G; Garcia-Segura LM; Caruso D; Melcangi RC
    Neuroscience; 2009 Dec; 164(2):520-9. PubMed ID: 19665520
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential efficacy of the TSPO ligands etifoxine and XBD-173 in two rodent models of Multiple Sclerosis.
    Ravikumar B; Crawford D; Dellovade T; Savinainen A; Graham D; Liere P; Oudinet JP; Webb M; Hering H
    Neuropharmacology; 2016 Sep; 108():229-37. PubMed ID: 27039042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancing neurosteroid synthesis--relationship to the pharmacology of translocator protein (18 kDa) (TSPO) ligands and benzodiazepines.
    Wolf L; Bauer A; Melchner D; Hallof-Buestrich H; Stoertebecker P; Haen E; Kreutz M; Sarubin N; Milenkovic VM; Wetzel CH; Rupprecht R; Nothdurfter C
    Pharmacopsychiatry; 2015 Mar; 48(2):72-7. PubMed ID: 25654303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Etifoxine improves sensorimotor deficits and reduces glial activation, neuronal degeneration, and neuroinflammation in a rat model of traumatic brain injury.
    Simon-O'Brien E; Gauthier D; Riban V; Verleye M
    J Neuroinflammation; 2016 Aug; 13(1):203. PubMed ID: 27565146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of clozapine treatment and other antipsychotics on the 18 kDa translocator protein, formerly named the peripheral-type benzodiazepine receptor, and steroid production.
    Danovich L; Veenman L; Leschiner S; Lahav M; Shuster V; Weizman A; Gavish M
    Eur Neuropsychopharmacol; 2008 Jan; 18(1):24-33. PubMed ID: 17561380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Comprehensive Steroidome in Complete TSPO/PBR Knockout Mice under Basal Conditions.
    Liere P; Liu GJ; Pianos A; Middleton RJ; Banati RB; Akwa Y
    Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768796
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long Residence Time at the Neurosteroidogenic 18 kDa Translocator Protein Characterizes the Anxiolytic Ligand XBD173.
    Costa B; Da Pozzo E; Cavallini C; Taliani S; Da Settimo F; Martini C
    ACS Chem Neurosci; 2016 Aug; 7(8):1041-6. PubMed ID: 27385308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human pharmacokinetics of XBD173 and etifoxine distinguish their potential for pharmacodynamic effects mediated by translocator protein.
    Owen DR; Phillips A; O'Connor D; Grey G; Aimola L; Nicholas R; Matthews PM
    Br J Clin Pharmacol; 2022 Sep; 88(9):4230-4236. PubMed ID: 35524344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurosteroid allopregnanolone mediates anxiolytic effect of etifoxine in rats.
    Ugale RR; Sharma AN; Kokare DM; Hirani K; Subhedar NK; Chopde CT
    Brain Res; 2007 Dec; 1184():193-201. PubMed ID: 17950705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axonal regeneration and neuroinflammation: roles for the translocator protein 18 kDa.
    Girard C; Liu S; Adams D; Lacroix C; Sinéus M; Boucher C; Papadopoulos V; Rupprecht R; Schumacher M; Groyer G
    J Neuroendocrinol; 2012 Jan; 24(1):71-81. PubMed ID: 21951109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A TSPO ligand attenuates brain injury after intracerebral hemorrhage.
    Li M; Ren H; Sheth KN; Shi FD; Liu Q
    FASEB J; 2017 Aug; 31(8):3278-3287. PubMed ID: 28416580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A TSPO ligand is protective in a mouse model of multiple sclerosis.
    Daugherty DJ; Selvaraj V; Chechneva OV; Liu XB; Pleasure DE; Deng W
    EMBO Mol Med; 2013 Jun; 5(6):891-903. PubMed ID: 23681668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.